Sarepta Therapeutics (SRPT) Q2 2022 Earnings Report

4,071 Followers

SRPT Q2 2022 EPS Results

Actual EPS: -$2.65
Consensus EPS: -$1.11
Beat/Miss: Missed by -$1.54
One Year Ago EPS: -$1.02

SRPT Q2 2022 Revenue Results

Actual Revenue: $233.49M
Expected Revenue: $220.81M
Beat/Miss: Beat by +$12.67M
YoY Revenue Growth: +42.29%

Earnings Announcement Details

Quarter: Q2 2022
Date: 08/02/2022
Time: After Close
Conference Call: Tuesday, August 2, 2022

SRPT Upcoming Earnings

Sarepta Therapeutics's next earnings date is estimated for March 3, 2027, based on past reporting schedules.

Q2 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

SRPT Earnings History

SRPT earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Mar 03, 2027	2026 (Q4)	-0.35-	-3.93	―	―
Nov 05, 2026	2026 (Q3)	0.08-0.27	-1.8	85.00% (+1.53)
Aug 05, 2026	2026 (Q2)	0.22-0.05	1.89	-102.65% (-1.94)
May 06, 2026	2026 (Q1)	0.982.88	-4.6	162.61% (+7.48)
Feb 25, 2026	2025 (Q4)	-1.20-3.93	1.5	-362.00% (-5.43)
Nov 03, 2025	2025 (Q3)	-0.73-1.80	0.34	-629.41% (-2.14)
Aug 06, 2025	2025 (Q2)	0.831.89	0.07	2600.00% (+1.82)
May 06, 2025	2025 (Q1)	-3.21-4.60	0.37	-1343.24% (-4.97)
Feb 26, 2025	2024 (Q4)	1.881.50	0.47	219.15% (+1.03)
Nov 06, 2024	2024 (Q3)	-0.070.34	-0.46	173.91% (+0.80)
Aug 07, 2024	2024 (Q2)	-0.130.07	-0.27	125.93% (+0.34)
May 01, 2024	2024 (Q1)	0.010.37	-5.86	106.31% (+6.23)
Feb 28, 2024	2023 (Q4)	0.070.47	-1.24	137.90% (+1.71)
Nov 01, 2023	2023 (Q3)	-1.22-0.46	-2.94	84.35% (+2.48)
Aug 02, 2023	2023 (Q2)	-1.78-0.27	-2.65	89.81% (+2.38)
May 02, 2023	2023 (Q1)	-1.29-5.86	-1.2	-388.33% (-4.66)
Feb 28, 2023	2022 (Q4)	-1.47-1.24	-1.42	12.68% (+0.18)
Nov 02, 2022	2022 (Q3)	-1.22-2.94	-0.6	-390.00% (-2.34)
Aug 02, 2022	2022 (Q2)	-1.11-2.65	-1.02	-159.80% (-1.63)
May 04, 2022	2022 (Q1)	-1.31-1.20	-2.1	42.86% (+0.90)
Mar 01, 2022	2021 (Q4)	-1.25-1.42	-2.4	40.83% (+0.98)
Nov 03, 2021	2021 (Q3)	-1.79-0.60	-2.5	76.00% (+1.90)
Aug 04, 2021	2021 (Q2)	-1.30-1.02	-1.93	47.15% (+0.91)
May 05, 2021	2021 (Q1)	―-2.10	-0.23	-813.04% (-1.87)
Mar 01, 2021	2020 (Q4)	―-2.40	-3.16	24.05% (+0.76)
Nov 05, 2020	2020 (Q3)	―-2.50	-1.7	-47.06% (-0.80)
Aug 05, 2020	2020 (Q2)	―-1.93	-3.74	48.40% (+1.81)
May 06, 2020	2020 (Q1)	―-0.23	-1.07	78.50% (+0.84)
Feb 26, 2020	2019 (Q4)	―-3.16	-2.05	-54.15% (-1.11)
Nov 07, 2019	2019 (Q3)	―-1.70	-1.15	-47.83% (-0.55)
Aug 07, 2019	2019 (Q2)	―-3.74	-1.67	-123.95% (-2.07)
May 08, 2019	2019 (Q1)	―-1.07	-0.55	-94.55% (-0.52)
Feb 27, 2019	2018 (Q4)	―-2.05	-0.37	-454.05% (-1.68)
Oct 24, 2018	2018 (Q3)	―-1.15	-0.78	-47.44% (-0.37)
Aug 08, 2018	2018 (Q2)	―-1.67	-1.15	-45.22% (-0.52)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Sarepta Therapeutics earnings date